ANL
ADLI NRTY SP ADS-A (ANL)
NASDAQ
$11.26-$0.32 (-2.76%)
Price as of Jun 03, 2026 4:10 PM EDT
  • $701.3M
    Market Cap
  • 606.05%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
5.0M
N/A
N/A
N/A
5.0M
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
5.0M
N/A
0
-100.00%
5.0M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
6.2M
N/A
Research and Development Expense
-32.8M
-26.90%
-44.9M
-22.76%
-58.2M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
8.3M
-17.00%
10.0M
+60.64%
6.2M
N/A
Operating Profit
-35.7M
-32.55%
-52.9M
-21.65%
-67.6M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-35.5M
-31.50%
-51.9M
-50.54%
-104.9M
N/A
Income Taxes
N/A
N/A
N/A
N/A
643,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-35.5M
-31.50%
-51.9M
-50.54%
-104.9M
N/A
Net Income from Continuing Operations Applicable to Common
-35.5M
-31.50%
-51.9M
-50.54%
-104.9M
N/A
Basic EPS and Net Income
-0.37
-31.48%
-0.54
-77.69%
-2.42
N/A
Diluted EPS and Net Income
-0.37
-31.48%
-0.54
-77.69%
-2.42
N/A
Basic Weighted Average Shares
95.9M
+0.15%
95.8M
+120.98%
43.3M
N/A
Diluted Weighted Average Shares
95.9M
+0.15%
95.8M
+120.98%
43.3M
N/A
Balance Sheet
Cash and Cash Equivalents
8.1M
-86.77%
60.9M
-33.43%
91.5M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.1M
-86.77%
60.9M
-33.43%
91.5M
N/A
Total Current Assets
26.9M
-58.02%
64.1M
-36.69%
101.2M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
1.2M
-30.06%
1.7M
-34.13%
2.6M
N/A
Total Long-Term Assets
7.5M
+4.65%
7.2M
-75.15%
29.0M
N/A
Total Assets
34.4M
-51.69%
71.3M
-45.26%
130.2M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
20,000
-99.80%
10.0M
-67.06%
30.4M
N/A
Total Current Liabilities
41.6M
-8.23%
45.4M
-9.85%
50.3M
N/A
Total Long-Term Debt
11.4M
-9.09%
12.5M
N/A
N/A
N/A
Total Long-Term Liabilities
1.1M
+165.18%
425,000
-9.38%
469,000
N/A
Total Liabilities
42.8M
-6.62%
45.8M
-9.85%
50.8M
N/A
Retained Earnings
-464.8M
+8.28%
-429.3M
+15.07%
-373.1M
N/A
Total Stockholders Equity
-8.3M
-132.65%
25.5M
-67.90%
79.4M
N/A
Total Shares Outstanding
103.0M
+9.92%
93.7M
-70.45%
317.1M
N/A
Cash Flow
Cash from Operating Activities
-33.5M
-35.44%
-51.8M
-8.53%
-56.7M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-15.6M
-155.51%
28.1M
+356.21%
-11.0M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-3.8M
-42.06%
-6.6M
-105.66%
116.2M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-713.96%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-67.22%
+30.55%
-51.49%
N/A
N/A
N/A
Return on Equity
-414.01%
+318.60%
-98.90%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.65
-54.26%
1.41
N/A
N/A
N/A
Cash Ratio
0.19
-85.59%
1.34
N/A
N/A
N/A
Debt-to-Equity Ratio
-1.37
-255.04%
0.88
N/A
N/A
N/A
Debt-to-Assets Ratio
0.33
+4.78%
0.32
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow